15 on COVID-19: Accelerated Vaccine Development

Activity Preview

Vaccine and drug development is a process that usually takes years, if not decades. Despite this, the scientific, medical, and regulatory communities pulled together to design, test, review and distribute COVID-19 vaccines in less than 12 months. How was this possible? Join us for this episode of our 15 on COVID-19 series to learn more about how we were able to safely develop COVID-19 vaccines in record time. We'll start with a review of the standard drug development process, and then take a look at how the process was accelerated without compromising any safety steps during the COVID-19 vaccine development process.

Learning Objectives

  • Describe the standard drug/vaccine development process
  • Discuss how the COVID-19 vaccine development process was accelerated without compromising safety

Activity type: Knowledge-based
Target Audience: Pharmacists and Pharmacy Technicians
Learning Level: 2

Accreditation Information


The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following archived webinar is approved for 0.25 contact hour of CPE credit (0.025 CEUs). The ACPE Universal Activity Number for this activity is 0202-9999-21-192-H06-P/T

To obtain credit for completing 15 on COVID-19: Accelerated Vaccine Development, participants will need to watch the archived webinar, complete the assessment, complete the evaluation, and then CLAIM credit. Participants need to have a valid pharmacist.com username and password and a valid CPE Monitor account to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.    

Initial release date: May 6, 2021
Expiration date: May 6, 2022 - No credit granted after this date

Development and Support

15 on COVID-19: Accelerated Vaccine Development is an activity for pharmacists and pharamacy technicians developed by the American Pharmacists Association. This project was funded in part by a collaborative agreement with the Centers for Disease Control and Prevention (CDC) - CoAg number 1 NU50CK000576-01-00. The CDC is an agency within the Department of Health and Human Services (HHS). Contents of this resource do not necessarily represent the CDC or HHS, and should not be considered endorsement by the Federal Government. © 2021 American Pharmacists Association


Daniel Zlott, PharmD, BCOP and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures

Conflicts of interest have been resolved through content review by Helen Sairany, BA, PharmD, MBA, BCACP, Director of Content Development & Partnership at the American Pharmacists Association. 

System Requirements

Computer and internet access are required to complete this activity.  Please visit our website to view the Technology System Requirements in order to have a positive learning experience.

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE# 0202-9999-21-192-H06-P 0.025 CEUs May 06, 2021 - May 06, 2022
ACPE# 0202-9999-21-192-H06-T 0.025 CEUs May 06, 2021 - May 06, 2022